Clinical Trial Update: Phase I/II Study to Evaluate the Safety and Tolerability of LiPlaCis in Patients With Advanced or Refractory Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial evaluating the safety and tolerability of LiPlaCis in patients with advanced or refractory tumours; trial completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Or Refractory Solid Tumours
• Prostate Cancer
• Skin Cancer

Drugs mentioned

• LiPlaCis (LiPlaCis)

Snippet

Sponsor: Allarity Therapeutics | Conditions: Phase 1: Advanced or Refractory Solid Tumours, Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin Cancer | Phase 1, Phase 2 | Status: COMPLETED